You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AIDS Vaccines

Showing 1 - 25 of 4,451
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)

Not yet recruiting
  • Sudan Ebola Virus Vaccines
  • CAd3
  • +3 more
  • (no location specified)
Jun 8, 2023

HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)

Active, not recruiting
  • HIV-1-infection
  • Vaccine
  • Placebo
  • Kilifi, Kenya
  • +3 more
Jun 21, 2022

COVID-19 Quantitative Antibody Titers & Booster Vaccinations

Completed
  • COVID-19
  • +2 more
  • Observational
  • New York, New York
    AHD Manhattan Midtown HCC
Jul 26, 2022

HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

Not yet recruiting
  • HIV-1-infection
  • VRC07-523LS
  • +7 more
  • Pathum Wan, Bangkok, Thailand
  • +1 more
Mar 8, 2023

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), HIV-1 Immunogen)

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • HIV-1 Immunogen
  • Los Angeles, California
  • +8 more
Oct 28, 2021

HIV, HIV Seronegativity Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, ALVAC-HIV

Completed
  • HIV Infections
  • HIV Seronegativity
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • +2 more
  • Long Beach, California
  • +16 more
Oct 27, 2021

HIV Trial in Worldwide (rAd5 Gag-Pol Env A/B/C, rAd5 Gag-Pol)

Completed
  • HIV Infections
  • rAd5 Gag-Pol Env A/B/C
  • rAd5 Gag-Pol
  • Boston, Massachusetts
  • +6 more
Oct 13, 2021

HIV/AIDS Trial in Spain (ChAdOx1.HTI, MVA.HTI, GS-9620)

Active, not recruiting
  • HIV/AIDS
  • ChAdOx1.HTI
  • +4 more
  • Badalona, Barcelona, Spain
  • +8 more
Jul 30, 2021

AIDS, AIDS Vaccines Trial in Gent (Blood sample collection)

Completed
Has Results
  • AIDS
  • AIDS Vaccines
  • Blood sample collection
  • Gent, Belgium
    GSK Investigational Site
Apr 14, 2020

COVID-19 Vaccine Effectiveness Among Health Workers in Georgia

Recruiting
  • Covid19
  • Covid-19 vaccines
  • Batumi, Ajara, Georgia
  • +5 more
Apr 29, 2021

HIV Trial in Badalona (DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM), At least 24 weeks since

Completed
  • HIV
  • DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM)
  • +2 more
  • Badalona, Barcelona, Spain
    IrsiCaixa AIDS Research Institute, Hospital Universitari Germans
Apr 7, 2021

HIV Trial in Brazil, United States (rMVA-HIV (rMVA-HIV env/gag + rMVA-HIV tat/rev/nef-RT), rFPV-HIV (rFPV-HIV env/gag + rFPV-HIV

Completed
  • HIV Infections
  • rMVA-HIV (rMVA-HIV env/gag + rMVA-HIV tat/rev/nef-RT)
  • +3 more
  • Birmingham, Alabama
  • +5 more
Oct 13, 2021

AIDS Vaccines, HIV, HIV-1 Trial run by the NIAID (VRC-HIVADV027-00-VP, VRC-HIVADV038-00-VP)

Completed
  • AIDS Vaccines
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019

HIV, Influenza Trial in Puerto Rico, United States (Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated

Completed
  • HIV Infections
  • Influenza
  • Cold-adapted live attenuated influenza vaccine (FluMist)
  • Inactivated influenza vaccine (IAIV)
  • Birmingham, Alabama
  • +60 more
Oct 28, 2021

HIV Trial in Saint Louis (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
    St. Louis Univ. School of Medicine AVEG
Oct 28, 2021

HIV Trial in Saint Louis, Rochester, Nashville (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

HIV Trial in Saint Louis, Pittsburgh, Nashville (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +2 more
Oct 27, 2021

HIV Trial (gp160 MN/LAI-2, Aluminum hydroxide)

Completed
  • HIV Infections
  • gp160 MN/LAI-2
  • Aluminum hydroxide
  • (no location specified)
Oct 13, 2021

HIV Trial in Pittsburgh, Nashville (Hepatitis B Vaccine (Recombinant), gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • Hepatitis B Vaccine (Recombinant)
  • gp160 Vaccine (MicroGeneSys)
  • Pittsburgh, Pennsylvania
  • +1 more
Oct 27, 2021

HIV Trial in United States (Combination Vaccine (NefTat and gp120W61D) Formulated with AS02A, NefTat, AS02A Adjuvant)

Completed
  • HIV Infections
  • Combination Vaccine (NefTat and gp120W61D) Formulated with AS02A
  • +3 more
  • Birmingham, Alabama
  • +14 more
Oct 13, 2021

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

HIV Trial in United States (DNA plasmid vaccine, Recombinant adenoviral serotype 5 (rAD5) vector vaccine, DNA vaccine )

Terminated
Has Results
  • HIV Infections
  • DNA plasmid vaccine
  • +3 more
  • Birmingham, Alabama
  • +21 more
Oct 13, 2021

Infants' Family Decide Baby's Vaccine Trial (Patients Decision Aids (PDA))

Not yet recruiting
  • Infants' Family Decide Baby's Vaccine
  • Patients Decision Aids (PDA)
  • (no location specified)
Oct 10, 2022

HIV Trial in Nashville, Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • HIVAC-1e
  • gp160 Vaccine (MicroGeneSys)
  • Nashville, Tennessee
  • +1 more
Oct 26, 2021

HIV, HIV Seronegativity Trial in Worldwide (ALVAC(2)120(B,MN)GNP (vCP1452), MN rgp120/HIV-1, ALVAC(2)120(B,MN)GNP (vCP1452) )

Completed
  • HIV Infections
  • HIV Seronegativity
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • +3 more
  • Rio de Janeiro, Brazil
  • +3 more
Oct 13, 2021